CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
Olmesartan Medoxomil

奥美沙坦酯 杂质对照品Olmesartan Medoxomil Impurities

EP81 个杂质条目81 impurity entries

本页汇总 奥美沙坦酯 的 81 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 81 impurity reference standards of Olmesartan Medoxomil with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 奥美沙坦酯(Olmesartan Medoxomil)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments
    Biomedical chromatography : BMC · 2021 · Marisetti VM et al.  ·  PMID 34110035  ·  DOI
  2. 杂质研究Impurity studiesDetermination of Olmesartan in Bulk and Pharmaceutical Dosage Forms through the Development and Validation of Stability-indicating RP-HPLC Method
    Drug metabolism and bioanalysis letters · 2023 · Agrawal AA et al.  ·  PMID 36843253  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and Validation of SI/RS-UHPLC-PDA Method for Olmesartan Medoxomil and Metoprolol Succinate-Related Substance
    Turkish journal of pharmaceutical sciences · 2023 · Thakker N et al.  ·  PMID 36864594  ·  DOI
  4. 分析方法Analytical MethodsValidated Spectrophotometric Methods for Simultaneous Determination of Atorvastatin Calcium and Olmesartan Medoxomil in Their Pharmaceutical Formulation
    Journal of AOAC International · 2022 · Kamal AH et al.  ·  PMID 34850012  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisA Competent and Commercially Viable Process for the Synthesis of the Anti-Hypertensive Drug Olmesartan Medoxomil
    Scientia pharmaceutica · 2015 · Hanumantha Rao B et al.  ·  PMID 26839831  ·  DOI

奥美沙坦酯 —— 原料药与杂质对照品Olmesartan Medoxomil — drug substance & impurities

共 82 个条目(含原料药本体)82 items incl. the drug substance
Olmesartan Medoxomil structure
EP原料药 APIAPI
奥美沙坦酯Olmesartan Medoxomil
Olmesartan Medoxomil
CAS No.144689-63-4
Chemical FormulaC29H30N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 1 (Olmesartan Medoxomil EP Impurity A) (Olmesartan) structure
EPA
奥美沙坦酯杂质1 (奥美沙坦酯EP杂质A) (奥美沙坦)Olmesartan Medoxomil Impurity 1 (Olmesartan Medoxomil EP Impurity A) (Olmesartan)
Olmesartan Medoxomil Impurity 1 (Olmesartan Medoxomil EP Impurity A) (Olmesartan)
CAS No.144689-24-7
Chemical FormulaC24H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 2 (Olmesartan Medoxomil EP Impurity B) structure
EPB
奥美沙坦酯杂质2(奥美沙坦酯EP杂质B)Olmesartan Medoxomil Impurity 2 (Olmesartan Medoxomil EP Impurity B)
Olmesartan Medoxomil Impurity 2 (Olmesartan Medoxomil EP Impurity B)
CAS No.849206-43-5
Chemical FormulaC24H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 3(Olmesartan Medoxomil EP Impurity C) structure
EPC
奥美沙坦酯杂质3(奥美沙坦酯EP杂质C)Olmesartan Medoxomil Impurity 3(Olmesartan Medoxomil EP Impurity C)
Olmesartan Medoxomil Impurity 3(Olmesartan Medoxomil EP Impurity C)
CAS No.879562-26-2
Chemical FormulaC29H28N6O5
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 10(Olmesartan Medoxomil EP Impurity D) structure
EPD
奥美沙坦酯杂质10(奥美沙坦酯EP杂质D)Olmesartan Medoxomil Impurity 10(Olmesartan Medoxomil EP Impurity D)
Olmesartan Medoxomil Impurity 10(Olmesartan Medoxomil EP Impurity D)
CAS No.1020157-01-0
Chemical FormulaC48H44N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 1-d6 (Olmesartan Medoxomil EP Impurity A-d6) (Olmesartan-d6) structure
EPA-D6
奥美沙坦酯杂质1-d6 (奥美沙坦酯EP杂质A-d6) (奥美沙坦-d6)Olmesartan Medoxomil Impurity 1-d6 (Olmesartan Medoxomil EP Impurity A-d6) (Olmesartan-d6)
Olmesartan Medoxomil Impurity 1-d6 (Olmesartan Medoxomil EP Impurity A-d6) (Olmesartan-d6)
CAS No.1185144-74-4
Chemical FormulaC24H20D6N6O3
Purity>95%询价On request
Olmesartan Medoxomil Impurity 4 structure
4
奥美沙坦酯杂质4Olmesartan Medoxomil Impurity 4
Olmesartan Medoxomil Impurity 4
CAS No.144690-92-6
Chemical FormulaC48H44N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 5 structure
5
奥美沙坦酯杂质5Olmesartan Medoxomil Impurity 5
Olmesartan Medoxomil Impurity 5
CAS No.1040250-19-8
Chemical FormulaC48H50N12O5
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 6 structure
6
奥美沙坦酯杂质6Olmesartan Medoxomil Impurity 6
Olmesartan Medoxomil Impurity 6
CAS No.896419-17-3
Chemical FormulaC30H32N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 7 structure
7
奥美沙坦酯杂质7Olmesartan Medoxomil Impurity 7
Olmesartan Medoxomil Impurity 7
CAS No.1227626-45-0
Chemical FormulaC25H28N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 8 structure
8
奥美沙坦酯杂质8Olmesartan Medoxomil Impurity 8
Olmesartan Medoxomil Impurity 8
CAS No.144689-23-6
Chemical FormulaC26H30N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 9 structure
9
奥美沙坦酯杂质9Olmesartan Medoxomil Impurity 9
Olmesartan Medoxomil Impurity 9
CAS No.1392475-91-0
Chemical FormulaC34H34N6O9
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 11 structure
11
奥美沙坦酯杂质11Olmesartan Medoxomil Impurity 11
Olmesartan Medoxomil Impurity 11
CAS No.2411637-68-6
Chemical FormulaC11H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 12 structure
12
奥美沙坦酯杂质12Olmesartan Medoxomil Impurity 12
Olmesartan Medoxomil Impurity 12
CAS No.144690-07-3
Chemical FormulaC11H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 13 structure
13
奥美沙坦酯杂质13Olmesartan Medoxomil Impurity 13
Olmesartan Medoxomil Impurity 13
CAS No.144689-94-1
Chemical FormulaC12H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 14 structure
14
奥美沙坦酯杂质14Olmesartan Medoxomil Impurity 14
Olmesartan Medoxomil Impurity 14
CAS No.1092980-84-1
Chemical FormulaC13H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 15 structure
15
奥美沙坦酯杂质15Olmesartan Medoxomil Impurity 15
Olmesartan Medoxomil Impurity 15
CAS No.172875-53-5
Chemical FormulaC13H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 16 structure
16
奥美沙坦酯杂质16Olmesartan Medoxomil Impurity 16
Olmesartan Medoxomil Impurity 16
CAS No.157356-73-5
Chemical FormulaC12H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 17 structure
17
奥美沙坦酯杂质17Olmesartan Medoxomil Impurity 17
Olmesartan Medoxomil Impurity 17
CAS No.116857-04-6
Chemical FormulaC5H6Cl2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 19 structure
19
奥美沙坦酯杂质19Olmesartan Medoxomil Impurity 19
Olmesartan Medoxomil Impurity 19
CAS No.161952-66-5
Chemical FormulaC14H11ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 20 structure
20
奥美沙坦酯杂质20Olmesartan Medoxomil Impurity 20
Olmesartan Medoxomil Impurity 20
CAS No.209911-63-7
Chemical FormulaC14H9Br2N
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 21 structure
21
奥美沙坦酯杂质21Olmesartan Medoxomil Impurity 21
Olmesartan Medoxomil Impurity 21
CAS No.1347262-29-6
Chemical FormulaC25H28N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 22 structure
22
奥美沙坦酯杂质22Olmesartan Medoxomil Impurity 22
Olmesartan Medoxomil Impurity 22
CAS No.172875-59-1
Chemical FormulaC45H44N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 23 structure
23
奥美沙坦酯杂质23Olmesartan Medoxomil Impurity 23
Olmesartan Medoxomil Impurity 23
CAS No.144690-53-9
Chemical FormulaC45H42N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 24 structure
24
奥美沙坦酯杂质24Olmesartan Medoxomil Impurity 24
Olmesartan Medoxomil Impurity 24
CAS No.761404-85-7
Chemical FormulaC43H40N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 25 structure
25
奥美沙坦酯杂质25Olmesartan Medoxomil Impurity 25
Olmesartan Medoxomil Impurity 25
CAS No.154709-18-9
Chemical FormulaC33H26N4O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 26 structure
26
奥美沙坦酯杂质26Olmesartan Medoxomil Impurity 26
Olmesartan Medoxomil Impurity 26
CAS No.1227626-51-8
Chemical FormulaC48H42N6O5
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 27 structure
27
奥美沙坦酯杂质27Olmesartan Medoxomil Impurity 27
Olmesartan Medoxomil Impurity 27
CAS No.1048948-15-7
Chemical FormulaC43H38N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 28 structure
28
奥美沙坦酯杂质28Olmesartan Medoxomil Impurity 28
Olmesartan Medoxomil Impurity 28
CAS No.157356-74-6
Chemical FormulaC45H42N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 30 structure
30
奥美沙坦酯杂质30Olmesartan Medoxomil Impurity 30
Olmesartan Medoxomil Impurity 30
CAS No.144690-04-0
Chemical FormulaC10H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 31 structure
31
奥美沙坦酯杂质31Olmesartan Medoxomil Impurity 31
Olmesartan Medoxomil Impurity 31
CAS No.58954-23-7
Chemical FormulaC8H10N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 32 structure
32
奥美沙坦酯杂质32Olmesartan Medoxomil Impurity 32
Olmesartan Medoxomil Impurity 32
CAS No.849206-42-4
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 34 structure
34
奥美沙坦酯杂质34Olmesartan Medoxomil Impurity 34
Olmesartan Medoxomil Impurity 34
CAS No.1878117-43-1
Chemical FormulaC34H34N6O9
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 36 structure
36
奥美沙坦酯杂质36Olmesartan Medoxomil Impurity 36
Olmesartan Medoxomil Impurity 36
CAS No.144690-33-5
Chemical FormulaC45H44N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 37 structure
37
奥美沙坦酯杂质37Olmesartan Medoxomil Impurity 37
Olmesartan Medoxomil Impurity 37
CAS No.172875-98-8
Chemical FormulaC24H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 38 structure
38
奥美沙坦酯杂质38Olmesartan Medoxomil Impurity 38
Olmesartan Medoxomil Impurity 38
CAS No.1039762-39-4
Chemical FormulaC46H46N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 40 structure
40
奥美沙坦酯杂质40Olmesartan Medoxomil Impurity 40
Olmesartan Medoxomil Impurity 40
CAS No.91526-17-9
Chemical FormulaC6H6O5
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 42 structure
42
奥美沙坦酯杂质42Olmesartan Medoxomil Impurity 42
Olmesartan Medoxomil Impurity 42
CAS No.124750-53-4
Chemical FormulaC33H26N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 43 structure
43
奥美沙坦酯杂质43Olmesartan Medoxomil Impurity 43
Olmesartan Medoxomil Impurity 43
CAS No.138402-33-2
Chemical FormulaC14H11BrN4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 44 structure
44
奥美沙坦酯杂质44Olmesartan Medoxomil Impurity 44
Olmesartan Medoxomil Impurity 44
CAS No.133051-88-4
Chemical FormulaC33H25BrN4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 45 structure
45
奥美沙坦酯杂质45Olmesartan Medoxomil Impurity 45
Olmesartan Medoxomil Impurity 45
CAS No.358685-13-9
Chemical FormulaC33H24Br2N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 46 structure
46
奥美沙坦酯杂质46Olmesartan Medoxomil Impurity 46
Olmesartan Medoxomil Impurity 46
CAS No.151052-34-5
Chemical FormulaC33H24Br2N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 47 structure
47
奥美沙坦酯杂质47Olmesartan Medoxomil Impurity 47
Olmesartan Medoxomil Impurity 47
CAS No.1127249-17-5
Chemical FormulaC14H10Br2N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 48 structure
48
奥美沙坦酯杂质48Olmesartan Medoxomil Impurity 48
Olmesartan Medoxomil Impurity 48
CAS No.155983-56-5
Chemical FormulaC33H24N4O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 50 structure
50
奥美沙坦酯杂质50Olmesartan Medoxomil Impurity 50
Olmesartan Medoxomil Impurity 50
CAS No.144689-93-0
Chemical FormulaC12H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 51 structure
51
奥美沙坦酯杂质51Olmesartan Medoxomil Impurity 51
Olmesartan Medoxomil Impurity 51
CAS No.1418133-29-5
Chemical FormulaC45H46N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 52 structure
52
奥美沙坦酯杂质52Olmesartan Medoxomil Impurity 52
Olmesartan Medoxomil Impurity 52
CAS No.1040405-56-8
Chemical FormulaC49H46N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 53 structure
53
奥美沙坦酯杂质53Olmesartan Medoxomil Impurity 53
Olmesartan Medoxomil Impurity 53
CAS No.1227626-50-7
Chemical FormulaC44H42N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 54 structure
54
奥美沙坦酯杂质54Olmesartan Medoxomil Impurity 54
Olmesartan Medoxomil Impurity 54
CAS No.37830-90-3
Chemical FormulaC5H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 56 structure
56
奥美沙坦酯杂质56Olmesartan Medoxomil Impurity 56
Olmesartan Medoxomil Impurity 56
CAS No.62458-20-2
Chemical FormulaC5H4O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 57 structure
57
奥美沙坦酯杂质57Olmesartan Medoxomil Impurity 57
Olmesartan Medoxomil Impurity 57
CAS No.80841-78-7
Chemical FormulaC5H5ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 58 structure
58
奥美沙坦酯杂质58Olmesartan Medoxomil Impurity 58
Olmesartan Medoxomil Impurity 58
CAS No.1443544-27-1
Chemical FormulaC5H4Cl2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 59 structure
59
奥美沙坦酯杂质59Olmesartan Medoxomil Impurity 59
Olmesartan Medoxomil Impurity 59
CAS No.95579-71-8
Chemical FormulaC5H5ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 62 structure
62
奥美沙坦酯杂质62Olmesartan Medoxomil Impurity 62
Olmesartan Medoxomil Impurity 62
CAS No.2101308-73-8
Chemical FormulaC44H40N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 63 structure
63
奥美沙坦酯杂质63Olmesartan Medoxomil Impurity 63
Olmesartan Medoxomil Impurity 63
CAS No.2101308-74-9
Chemical FormulaC44H40N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 64 structure
64
奥美沙坦酯杂质64Olmesartan Medoxomil Impurity 64
Olmesartan Medoxomil Impurity 64
CAS No.51802-42-7
Chemical FormulaC8H8N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 65 structure
65
奥美沙坦酯杂质65Olmesartan Medoxomil Impurity 65
Olmesartan Medoxomil Impurity 65
CAS No.144690-06-2
Chemical FormulaC9H11N3O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 66 structure
66
奥美沙坦酯杂质66Olmesartan Medoxomil Impurity 66
Olmesartan Medoxomil Impurity 66
CAS No.124750-51-2
Chemical FormulaC33H25BrN4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 67 structure
67
奥美沙坦酯杂质67Olmesartan Medoxomil Impurity 67
Olmesartan Medoxomil Impurity 67
CAS No.2382294-55-3
Chemical FormulaC5H6Cl2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 68 structure
68
奥美沙坦酯杂质68Olmesartan Medoxomil Impurity 68
Olmesartan Medoxomil Impurity 68
CAS No.129482-56-0
Chemical FormulaC5H6Cl2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 69 structure
69
奥美沙坦酯杂质69Olmesartan Medoxomil Impurity 69
Olmesartan Medoxomil Impurity 69
CAS No.116857-05-7
Chemical FormulaC5H6Cl2O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 70 structure
70
奥美沙坦酯杂质70Olmesartan Medoxomil Impurity 70
Olmesartan Medoxomil Impurity 70
CAS No.1227626-44-9
Chemical FormulaC28H26N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 71 structure
71
奥美沙坦酯杂质71Olmesartan Medoxomil Impurity 71
Olmesartan Medoxomil Impurity 71
CAS No.2347585-74-2
Chemical FormulaC28H26N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 72 structure
72
奥美沙坦酯杂质72Olmesartan Medoxomil Impurity 72
Olmesartan Medoxomil Impurity 72
CAS No.885216-74-0
Chemical FormulaC33H25ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 75 structure
75
奥美沙坦酯杂质75Olmesartan Medoxomil Impurity 75
Olmesartan Medoxomil Impurity 75
CAS No.1378863-74-1
Chemical FormulaC30H32N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 77 structure
77
奥美沙坦酯杂质77Olmesartan Medoxomil Impurity 77
Olmesartan Medoxomil Impurity 77
CAS No.14309-25-2
Chemical FormulaC19H15N3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 78 structure
78
奥美沙坦酯杂质78Olmesartan Medoxomil Impurity 78
Olmesartan Medoxomil Impurity 78
CAS No.2243064-11-9
Chemical FormulaC5H5N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 79 structure
79
奥美沙坦酯杂质79Olmesartan Medoxomil Impurity 79
Olmesartan Medoxomil Impurity 79
CAS No.133909-97-4
Chemical FormulaC33H26N4
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 80 structure
80
奥美沙坦酯杂质80Olmesartan Medoxomil Impurity 80
Olmesartan Medoxomil Impurity 80
CAS No.1073117-27-7
Chemical FormulaC45H38N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 81 structure
81
奥美沙坦酯杂质81Olmesartan Medoxomil Impurity 81
Olmesartan Medoxomil Impurity 81
CAS No.1073117-28-8
Chemical FormulaC54H52N6O9
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 82 structure
82
奥美沙坦酯杂质82Olmesartan Medoxomil Impurity 82
Olmesartan Medoxomil Impurity 82
CAS No.1867269-66-6
Chemical FormulaC35H38N6O9
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 86 structure
86
奥美沙坦酯杂质86Olmesartan Medoxomil Impurity 86
Olmesartan Medoxomil Impurity 86
CAS No.138804-35-0
Chemical FormulaC33H24N4O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 90 structure
90
奥美沙坦酯杂质90Olmesartan Medoxomil Impurity 90
Olmesartan Medoxomil Impurity 90
CAS No.1418133-31-9
Chemical FormulaC53H54N12O8
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 95 structure
95
奥美沙坦酯杂质95Olmesartan Medoxomil Impurity 95
Olmesartan Medoxomil Impurity 95
CAS No.1227626-49-4
Chemical FormulaC47H40N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 99 structure
99
奥美沙坦酯杂质99Olmesartan Medoxomil Impurity 99
Olmesartan Medoxomil Impurity 99
CAS No.171103-00-7
Chemical FormulaC8H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 102 structure
102
奥美沙坦酯杂质102Olmesartan Medoxomil Impurity 102
Olmesartan Medoxomil Impurity 102
CAS No.644-08-6
Chemical FormulaC13H12
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 103 structure
103
奥美沙坦酯杂质103Olmesartan Medoxomil Impurity 103
Olmesartan Medoxomil Impurity 103
CAS No.105235-65-2
Chemical FormulaC5H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 105 structure
105
奥美沙坦酯杂质105Olmesartan Medoxomil Impurity 105
Olmesartan Medoxomil Impurity 105
CAS No.2616662-61-2
Chemical FormulaC17H16N4O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 111 structure
111
奥美沙坦酯杂质111Olmesartan Medoxomil Impurity 111
Olmesartan Medoxomil Impurity 111
CAS No.135050-95-2
Chemical FormulaC33H26N4O
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 116 structure
116
奥美沙坦酯杂质116Olmesartan Medoxomil Impurity 116
Olmesartan Medoxomil Impurity 116
CAS No.2190492-40-9
Chemical FormulaC48H43ClN6O6
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 117 Sodium Salt structure
117
奥美沙坦酯杂质117 钠盐Olmesartan Medoxomil Impurity 117 Sodium Salt
Olmesartan Medoxomil Impurity 117 Sodium Salt
CAS No.1227626-48-3
Chemical FormulaC42H35N6O3-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Olmesartan Medoxomil Impurity 117 structure
117
奥美沙坦酯杂质117Olmesartan Medoxomil Impurity 117
Olmesartan Medoxomil Impurity 117
CAS No.1227664-85-8
Chemical FormulaC42H36N6O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

奥美沙坦酯 —— 研究文献与合成路线Olmesartan Medoxomil — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 奥美沙坦酯 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Olmesartan Medoxomil. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments
    Marisetti VM, Katakam P, Siddhani VK, et al. · Biomedical chromatography : BMC · 2021 · 被引 3cited 3
  2. Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of Olmesartan Medoxomil and Metoprolol Succinate in pharmaceutical dosage form
    Thakker NM, Panchal HB, Rakholiya DR, et al. · Pharmaceutical methods · 2012 · 被引 5cited 5
  3. Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?
    Dams I, Ostaszewska A, Puchalska M, et al. · Molecules (Basel, Switzerland) · 2015 · 被引 7cited 7
  4. Development and Validation of SI/RS-UHPLC-PDA Method for Olmesartan Medoxomil and Metoprolol Succinate-Related Substance
    Thakker N, Shinde G, Dharamsi A, et al. · Turkish journal of pharmaceutical sciences · 2023 · 被引 2cited 2
  5. "Ghost peaks" of olmesartan medoxomil: Two solution degradation products of olmesartan medoxomil via oxidation mediated by metal ions
    Huang M, Yao B, Jiang M, et al. · Journal of mass spectrometry : JMS · 2022
  6. Olmesartan medoxomil with reduced levels of impurities
    HEDVATI LILACH, PILARSKI GIDEON · 2009

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL
    PRASAD MOHAN, KAPOOR ASHWINI KUMAR, MEHTA HITEN SHARADCHANDRA, NATH ASOK · 公开号 MX2011012460MX2011012460 · 2012
  2. PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL
    KAPOOR ASHWINI KUMAR, MEHTA HITEN SHARADCHANDRA, NATH ASOK, PRASAD MOHAN · 公开号 WO2010134052WO2010134052 · 2010
  3. Process for the preparation of olmesartan medoxomil
    KAPOOR ASHWINI KUMAR, MEHTA HITEN SHARADCHANDRA, NATH ASOK, PRASAD MOHAN · 公开号 AU2010250827AU2010250827 · 2012
  4. PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL
    KAPOOR ASHWINI KUMAR, MEHTA HITEN SHARADCHANDRA, NATH ASOK, PRASAD MOHAN · 公开号 EP2432777EP2432777 · 2012
  5. PREPARATION OF OLMESARTAN MEDOXOMIL
    KOLLA NAVEEN KUMAR, MANNE NAGARAJU, NAREDLA ANITHA, SHINDE SACHIN GULABRAO · 公开号 WO2011014611WO2011014611 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

奥美沙坦酯 杂质谱研究要点Olmesartan Medoxomil — impurity profiling notes

下面这些是拿到 奥美沙坦酯 的 82 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 82 impurity entries for Olmesartan Medoxomil, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances